Physician profile
Dirk D Ruffin
NPI 1467496778
$1,056.41
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $53.34 · 2021: $28.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $247.06 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $217.31 | 2019 | |
| Abbvie INC. | $112.85 | 2019-2020 | |
| Vertiflex, INC. | $69.93 | 2019 | |
| Lilly USA, LLC | $66.56 | 2019-2020 | |
| Glaxosmithkline, LLC. | $60.05 | 2019 | |
| Radius Health, INC. | $48.42 | 2019 | |
| Boston Scientific Corporation | $41.46 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $36.74 | 2019 | |
| Sanofi Pasteur INC. | $28.16 | 2019 | |
| Amarin Pharma, INC. | $22.07 | 2019 | |
| Pfizer INC. | $19.62 | 2019 | |
| Melinta Therapeutics, LLC | $19.06 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.74 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.23 | 2019 | |
| Novo Nordisk INC | $15.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dirk Ruffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.